ArraySlide 24-4 chamber

Product Code: MA-24-4c

ArraySlide 24-4 chamber to hold 4 slides with 24 compartments per slide. For incubation with various samples in parallel.Amount: 1 Array Slide chamber for four slides with 24 compartments per slideApplication(s): Seromarker discovery, Humoral immune response, Peptide microarray incubation, Antibody epitope discovery, Binding experimentsIndication(s)/Topic(s): Microarray accessoryDelivery Time: 2-5 days

JPTs Array Slide Chamber ArraySlide chamber, including lower carrier tray, upper structure plate, and gasket to hold 4 slides for incubation. In combination with tailored PepStar™ Peptide Microarrays or RepliTope™ Peptide Microarrays that are printed in multiwell format, 21 samples per peptide microarray slide can be incubated in parallel. The ArraySlide chamber sections peptide microarrays into individual surfaces for multiple simultaneous screening analysis studies. Please contact us at webshop@jpt.com for details on peptide microarrays printed in multiwell format!

Benefits of Array Slide Chamber - Easy loading by multi-channel pipettes or automated robots- Utilizes leak free compression fit gasket - No contaminating adhesives

ArraySlide 24-4 chamber

Selected References for JPTs Peptide Microarrays\"Structure of GPN-loop GTPase Npa3 and Implications for RNA Polymerase II Assembly\" Niesser t al., Mol Cell Biol. (2015) - PMID: 26711263 \"Protective Efficacy of Adenovirus-protein Vaccines Against SIV Challenges in Rhesus Monkeys\" Barouch et al., Science (2015) - PMID: 26138104\"Identification and Characterization of Common B Cell Epitope in Bovine Leukemia Virus via High-throughput Peptide Screening System in Infected Cattle\" Bai et al., Retrovirology (2015) - PMID: 26715158\"High-Throughput Microarray Incubations Using Multi-Well Chambers\" Zerweck et al., Methods Mol Biol. (2015) - PMID: 26490464\"Peptide Microarrays for Coverage of Sequence Diversity in Monitoring the B cell Immune Response (TECH2P.911)\" Castro, et al., The Journal of Immunology (2015) - PMID: n.a.\"Antibodies to Influenza Nucleoprotein Cross-react with Human Hypocretin Receptor 2\" Ahmed et al., Science Translational Medicine (2015) - PMID: 26136476\"Serum Reactome Induced by Bordetella Pertussis Infection and Pertussis Vaccines: Qualitative Differences in Serum Antibody Recognition Patterns Revealed by Peptide Microarray Analysis\" Valentini et al., BMC Immunol. (2015) - PMID: 26129684

Application Notes\"A Modular Approach for Epitope Discovery and High-Resolution Profiling of Humoral Immune Responses\" Pawlowski et al. (2013) Full text\"Multiple Sclerosis and Epstein Barr Virus Infection. An Epitope Mapping Study\" Reimer et al. (2014) Full text\"The Challenge of Antigen Sequence Diversity:Solutions with ULTRA Peptide Libraries\" Pawlowski et al. (2015) Full text\"Rapid Mimotope Optimization for Pharmacokinetic Analysis of the Novel Therapeutic antibody IMAB362\" Daneschar et al. (2014) Full text

Testimonials for JPTs Peptide Microarrays \"Over the past five years my research team has been active in the development of species-specific peptide arrays. Our ability to advance this technology into new research areas has been dependent on working with the highest quality of arrays. In this regard, JPTs commitment to excellence has been a critical foundation for the success of our research program. I have been consistently impressed with their customer service, technical expertise and professionalism. When it comes to peptide work there are no other options for our group, JPT is the best.\"Scott Napper, PhD, Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Canada\"The RV 144 HIV trial is considered as one of first successful HIV vaccine trials. It has become clear that the V2 loop of gp120 is an important site for immunogenicity and protection from HIV infection. The use of JPTs PepStar™ microarray technology has been very useful for the correlation of the clincial outcome with humoral immune responses. As have the cyclic peptides been from JPT to validate these findings!.\"Jeff Currier, PhD, Walter Reed Army Institute, Rockville, Maryland, USA \"We study modulation of dopaminergic neurotransmisson by TAAR1 and D2R. The functional interaction of the two receptors in the brain supports TAAR1 as a target for the treatment of psychiatric disorders such as schizophrenia or bipolar disorder. To map the epitopes of our newly generated specific anti-rat TAAR1 antibodies we used JPTs PepStarTM peptide microarrays. The peptide microarrays greatly contributed to our successful and recently published study. We were very satisified with the exceptional product and service delivered by JPT Peptide Technologies as well as their scientific Customer Support which was always at our disposal.\" Stefan Obermüller, F.Hoffmann - La Roche Ltd., Roche Pharma Research and Early Development, Basel, Switzerland

ArraySlide 24-4 chamber